Torque-Certified Jars Reach Mainstream Regional Generic Majors
Pharmaceutical screw top jars, which use engineered precision-threaded and torque-calibrated construction intended to maximize closure integrity and reduce leakage risk rather than relying on conventional food-grade threaded jars alone, have moved from niche flagship premium pharmaceutical majors into mainstream regional generic manufacturers since 2023 as torque-certification production costs declined enough to reach smaller regional manufacturers worldwide overall. This documented closure advantage addresses genuine leakage concerns conventional threading alone could never satisfy. Regulators now require certified torque ratings for export programs worldwide this cycle. Documentation standards continue tightening across most tracked manufacturer programs. A closely related view comes from the hermetic jars market, which MMA projects to grow at a 5.6% CAGR to USD 4.15 billion by 2036.
Market Impact: Adds 3% globally driven demand








